P7C3
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No








P7C3
Background:
P7C3 exerts proneurogenic activity by protecting newborn neurons from apoptosis. Prolonged administration to aged rats impedes neuronal death and preserves cognitive capacity (1). Delays disease progression in G93A-SOD2 mutant mouse model of amyotrophic lateral sclerosis (2). Blocks MPTP-mediated cell death of dopaminergic neurons in the substantia nigra of adult mice, a model of Parkinson's disease (3). Restores hippocampal neurogenesis in a mouse model of Down Syndrome (4). The mechanism of action involves activation of nicotinamide phosphoribosyltransferase (NAMPT) with concomitant increase of intracellular levels of NAD (5). Active in vivo.Description:
NAMPT activatorProduct Name Alternative:
1- (3,6-dibromo-9H-carbazol-9-yl) -3- (phenylamino) propan-2-ol; AK34095UNSPSC:
41116105Type:
ActivatorSource:
SyntheticField of Research:
Cancer | Apoptosis | Neuroscience | Neurodegeneration | Alzheimer's Disease | Parkinson's Disease | Cardiovascular System | Angiogenesis | Cardiovascular Growth Factors | VEGF | VEGF Receptors | Atherosclerosis | Diabetes Associated | Cancer | Cell Cycle | p53 PathwayPurity:
>98% (TLC) ; NMR (Conforms)Weight:
0.005Format:
Off-white powderSolubility:
May be dissolved in DMSO (40 mg/ml)Molecular Formula:
C21H18Br2N2OMolecular Weight:
474.2Precautions:
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.References & Citations:
1. AA Pieper et al. Cell 2010 142:39 2. T Tesla et al. Proc. Natl. Acad. Sci. USA 2012 109:17016 3. H De Jesus-Cortes et al. Proc. Natl. Acad. Sci. USA 2012 109:17010 4. SE Latchney et al. Neurosci. Lett. 2015 591:86 5. G Wang et al. Cell 2014 158:1324CAS Number:
301353-96-8
